Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MOB kinase activator 1A pseudogene 2 (MOB1AP2) is a human pseudogene and does not produce a functional protein. It is classified as a pseudogene because it lacks protein-coding capability, likely due to mutations or genomic rearrangement. While some pseudogenes can play regulatory roles—such as generating non-coding RNAs that influence gene expression—there is no evidence that MOB1AP2 has an established biological or clinical function. It is not a drug target, and there are no drugs, biomarkers, or disease roles associated with this gene[1][3]. The parent functional proteins of the MOB family, notably MOB1A/B, are key adaptors in the Hippo signaling pathway involved in cell cycle and tissue growth; however, MOB1AP2 itself is not implicated in these pathways due to its pseudogene status[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MOB kinase activator 1A pseudogene 2 (MOB1AP2).